Ouvrages publiés en collaboration (1)
Parties d'ouvrages collectifs (4)
Articles dans des revues avec comité de lecture (86)
1.
Zwingli, G., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lopez Lobato, M., Nascimento Osorio, A., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., Fischer, D., & Henzi, B. C. (2026). Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial. Neuromuscular disorders, 61, 106366. doi:10.1016/j.nmd.2026.1063662.
Winzig, F., De Keukeleere, K., Bartholomeus, E., Deconinck, N., Barrea, C., Matthijs, I., Jansen, A. C. M. A., Verhelst, H., Dielman, C., Kuznetsova, M., Ha, M., Suls, A., Van Der Sluis, R. R., Ogunjimi, B., & Mogensen, T. H. (2026). Genetic Landscape of a Cohort of Children with Varicella Zoster Virus Encephalitis, Cerebellitis, and Stroke. The Journal of infectious diseases, 233(3), 510-520. doi:10.1093/infdis/jiaf4483.
Iannotta, A., Mongold, S. J., Yildiran Carlak, E., Georgiev, C., Cabaraux, P., Van Dyck, D., Naeije, G., Vander Ghinst, M., Foucart, J., Deconinck, N., & Bourguignon, M. (2025). Proprioceptive and visual motion detection acuity contribute to children's dynamic postural control. Scientific reports, 15(1), 41090. doi:10.1038/s41598-025-24975-94.
Neuens, S., Soblet, J., Penninckx, A., Detry, C., Badoer, C., Desmyter, L., Peyrassol, X., Wilkin, F., Busson, A., Bruneau, M., Grenet, M.-L., Le Morillon, A., Aeby, A., Deconinck, N., Prigogine, C., Monier, A., Juvené, E., Balfroid, T., Van Hecke, A., Christiaens, F., Depondt, C., Brachet, C., Delvenne, V., Lufin, N., Bouysran, Y., Kammoun, M., Daneels, D., Caljon, B., Croes, D., Olsen, C., Van Dooren, S., Migeotte, I., Vandernoot, I., Marangoni, M., Coppens, S., Smits, G., & Vilain, C. (2025). Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders. European journal of medical genetics, 105030. doi:10.1016/j.ejmg.2025.1050305.
Henzi, B. C., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lobato, M. L., Osorio, A. N., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., & Fischer, D. (2025). Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B). Neuromuscular disorders, 47, 105275. doi:10.1016/j.nmd.2025.1052756.
Ruiz Chicaiza, P., Kaleeta Maalu, J.-P., Chéron, G., Cebolla Alvarez, A. M., & Deconinck, N. (2024). Gait analysis in children with Duchenne Muscular Dystrophy: Overground vs. Treadmill walking. Gait & posture, 113, 196-197. doi:10.1016/j.gaitpost.2024.07.2117.
Akodad, S., Desmedt, D., Baijot, S., Stevens, H., & Deconinck, N. (2024). Cognition and communication in patients with spinal muscular atrophy: A systematic review. Heliyon, 10(e33677).